1Suppliers
0Customers
1Debt Items
0Related Chains
Anebulo Pharmaceuticals, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
| VERNALIS |
VERNALIS |
90%
|
We have access to certain regulatory materials, including study reports from clinical and non-clinical trials, under Vernalis' control. |
Anebulo Pharmaceuticals, Inc. Customers
No clients on recordNo downstream customers found in our database for Anebulo Pharmaceuticals, Inc..
Anebulo Pharmaceuticals, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| ANEB-DEBT-7757 |
Warrants outstanding: 26626710 |
90%
|
xbrl warrant detail from xbrl 2021-06-30. |
Anebulo Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Anebulo Pharmaceuticals, Inc..
Anebulo Pharmaceuticals, Inc. Ownership
| Holder | Name | Confidence | Evidence |
| ANEB-OWNER-MORGAN-STANLEY |
MORGAN STANLEY |
90%
|
13F overlay lists MORGAN STANLEY as top holder; 2 tracked holders. |
Anebulo Pharmaceuticals, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.